KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Synopsys (SNPS) Cash & Equivalents (2016 - 2026)

Synopsys (SNPS) has disclosed Cash & Equivalents for 17 consecutive years, with $2.9 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents fell 25.92% year-over-year to $2.9 billion, compared with a TTM value of $2.9 billion through Oct 2025, down 25.92%, and an annual FY2025 reading of $2.9 billion, down 25.92% over the prior year.
  • Cash & Equivalents was $2.9 billion for Q4 2025 at Synopsys, down from $3.7 billion in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $3.9 billion in Q4 2024 and bottomed at $1.0 billion in Q1 2021.
  • Average Cash & Equivalents over 5 years is $1.8 billion, with a median of $1.5 billion recorded in 2021.
  • Peak annual rise in Cash & Equivalents hit 227.7% in 2025, while the deepest fall reached 25.92% in 2025.
  • Year by year, Cash & Equivalents stood at $1.4 billion in 2021, then fell by 1.07% to $1.4 billion in 2022, then grew by 18.54% to $1.7 billion in 2023, then soared by 131.64% to $3.9 billion in 2024, then dropped by 25.92% to $2.9 billion in 2025.
  • Business Quant data shows Cash & Equivalents for SNPS at $2.9 billion in Q4 2025, $3.7 billion in Q1 2025, and $3.9 billion in Q4 2024.